Disease modifying drugs for rheumatoid arthritis: yesterday's treatment today or today's treatment tomorrow?
- 1 October 1990
- journal article
- review article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 30 (4) , 501-510
- https://doi.org/10.1111/j.1365-2125.1990.tb03807.x
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Rational Use of Disease-Modifying Antirheumatic DrugsDrugs, 1990
- Double‐blind trial of recombinant γ‐interferon versus placebo in the treatment of rheumatoid arthritisArthritis & Rheumatism, 1989
- Ciprofloxacin and Rheumatoid Arthritis–Lack of EffectRheumatology, 1989
- THE USE OF A PHARMACOLOGICAL INDICATOR TO INVESTIGATE COMPLIANCE IN PATIENTS WITH A POOR RESPONSE TO ANTIRHEUMATIC THERAPYRheumatology, 1988
- STUDY OF SULPHAMETHOXAZOLE IN RHEUMATOID ARTHRITISRheumatology, 1986
- Second line therapy in rheumatoid arthritis — A four year prospective studyClinical Rheumatology, 1985
- A rheumatological dilemma: is it possible to modify the course of rheumatoid arthritis? Can we answer the question?Annals of the Rheumatic Diseases, 1985
- A comparison of therapies which may influence trace metals in rheumatoid arthritisClinical Rheumatology, 1984
- Oral gold for rheumatoid arthritis.BMJ, 1984
- LEVAMISOLE IN RHEUMATOID ARTHRITIS: A Randomised Double-blind Study Comparing Two Dosage Regimens of Levamisole with PlaceboThe Lancet, 1978